INTRODUCTION
The development of microfluidic sample processing and microvalve technology offers significant opportunities for the miniaturization and large-scale integration of automated laboratory systems. Integrated microvalve control enables precise metering of nanoliter-scale sample volumes through networks of microchannels. 1e4 Functions including on-chip pumping, reagent mixing, and droplet generation have been used to automate a wide range of biomolecular assays. The structure of the normally closed, monolithic membrane valves developed by our group is illustrated in Figure 1 . These monolithic membrane valves have been used to automate a wide range of applications from single nucleotide polymorphism-based DNA computing 5 to nanoliter-scale Sanger DNA sequencing. 6 Here, we report on recent advances in the development of two digital microfluidic platforms enabled by microvalve technology that achieve massively parallel biomarker analysis, and an unprecedented level of programmability for assay automation.
MICROFLUIDIC AUTOMATON
A digital microfluidic automaton has been developed, based on two-dimensional microvalve array technology, for sample processing and analysis (Fig. 2) . Digital transfer of fluids between microvalves enables precise and rapid metering of nanoliter-scale sample volumes through programmable valve networks within the array. 7 The basic program for the transfer of fluids between microvalves in a rectilinear array begins with a single open microvalve filled with fluid. An adjacent microvalve is opened, drawing fluid from the first valve. The first valve is then closed with an applied pneumatic pressure, forcing the remainder of the fluid into the second valve. A 120-nL bolus of fluid is transferred between the microvalves under optimal conditions. Programs for reagent routing, mixing, rinsing, serial dilution, storage/ retrieval, and many other operations have been developed. High-level device programming enables rapid automation of diverse assay protocols on a common chip format. Previous programmable digital microfluidic platforms have been demonstrated using electrowetting arrays; 8e10 however, these systems often suffer from significant imprecision in droplet splitting operations, thus limiting quantitative control. 11 The pneumatically actuated microvalve array is composed of a three-layer glass polydimethylsiloxane (PDMS) hybrid structure, 1 and incorporates a rectilinear network of fluidic channels. Vacuum and pressure are supplied to the microvalves through drilled inputs on the pneumatic layer via computer-actuated solenoid valves. Samples and reagents can be loaded from drilled fluidic reservoirs to any subset of the microvalves by a programmed actuation sequence. The channels in the pneumatic layer are isotropically etched to a depth of 70 mm, whereas the fluidic features are etched to a depth of 30 mm to reduce dead volumes between the microvalves.
Programmable microfluidic systems for assay automation typically require active mixing mechanisms due to the laminar flow profile of fluids within microchannels. 12 Rapid reagent mixing is achieved with the automaton by cyclically transferring the contents of two or more valves within a loop. For instance, an eight-step, 640 ms subroutine is iterated to cycle the contents of two microvalves through a four-valve loop. Dilution of fluorescein standards with buffer and analysis by fluorescence microscopy indicate this mixing is complete in less than 5 s (Fig. 3A) . The digital fluidic transfers used in these programs result in mixing operations that are more than five times faster than traditional microfluidic mixing loops. 13 Figure 3B shows data from three consecutive fluorescein dilution operations with intermediate valve rinsing steps. This serial processing program results in highly reproducible mixing proportions for nanoliter-scale sample volumes. Furthermore, rinsing programs enable reuse of valve networks for different operations at different time points in a program. The output from a mixing circuit can be stored for future retrieval, or it can be used as the input for downstream processing operations. Iteration of the mixing program enables rapid generation of precise serial dilutions with adjustable dilution factors. Because the dead volumes of an individual microvalve can be used as a carryover fraction, as little as 14 nL can be precisely metered and mixed using the current design, and subnanoliter volumes could be similarly controlled by reducing the etch depth of fluidic features. More complex operations involving larger reagent sets can be achieved by using larger microvalve circuits for mixing. Figure 4 shows video frames of a program in which all possible combinations of a set of four reagents are prepared. The program is initialized by loading a subset of the four input reagents to the mixing loop. The same program can then be used to mix the reagents regardless of the size of the loaded subset. The scale of these operations can be increased by simply including more microvalves in the mixing circuit.
Several of the basic operations described above were combined to develop a rapid, quantitative assay for H 2 O 2 , a biomarker of oxidative stress ( Fig. 5 ). Elevated serum H 2 O 2 is an indicator for oxidative cellular damage in conditions such as chronic allopathic neuropathy, the leading cause of kidney transplant failure. 14 In this program, a H 2 O 2 standard was serially diluted, stored, mixed with horseradish peroxidase and aminophenyl fluorescein, and analyzed using laser-induced fluorescence to produce an on-chip calibration. After introduction of sample, this fully automated program achieves a submicromolar limit of detection with a 14-min runtime. Samples of H 2 O 2 (5.0 mM) prepared at the normal human serum concentration are quantified with a high level of precision and less that 4% error. Furthermore, this program can be extended to a wide range of metabolic analytes without modification.
We have recently enhanced the capabilities of this platform by developing procedures for inhomogeneous immunoassays. Magnetic microspheres coated with a capture antibody are loaded into specific microvalves in the array by trapping them in an external magnetic field ( Fig. 6A ). An individual capture microvalve is held continuously open while adjacent microvalves are actuated to transfer the antibody-coated microbeads from an inlet. External application of an 1/8th-in. diameter cylindrical neodymium magnet to the pneumatic wafer traps the magnetic microbeads only in the selected capture microvalve. The amount of beads loaded to the capture microvalve is adjusted based on the actuation rate and total program runtime.
To demonstrate a fluorescence enzyme-linked immunosorbent assay, we used magnetic microbeads coated with Fcspecific goat antimouse Immunoglobulin G (IgG) (Bangs Labs, BM550, Fishers, IN). Figure 6B illustrates the immune complex formed to detect mouse IgG. Before starting the assay, all microvalves and channels were treated with Superblock (Thermo Scientific, Waltham, MA). Approximately, 150 ng of beads were transferred to each capture microvalve as described above. Capture microvalves were held continuously opened for the duration of the assay. A total of 3 mL mouse IgG (Trevgen 4360-MC-100) in Superblock was transferred through the capture microvalve in a continuous pumping mode to a designated waste outlet. A similar program was used to rinse unbound analyte from the capture microvalves. We found that opened capture microvalves could be effectively rinsed in less than 30 s using tris-buffered saline tween-20 ( Fig. 6C ). After loading 0.8 mg/mL horseradish peroxidase-conjugated antimouse IgG (Santa Cruz Biotechnology, SC-2371, Santa Cruz, CA) and rinsing as described above, capture microvalves were filled with amplex red detection reagent (Invitrogen, A22188, Carlsbad, CA). After a 5-min incubation, the capture microvalves were imaged using epifluorescence microscopy. Figure 6D , E shows the increase in fluorescence signal observed for a mouse IgG positive control after the 5-min incubation. These results indicate successful capture and detection of a protein target using the digital microfluidic automaton without additional surface modification steps.
We have shown the utility of our digital microfluidic automaton for the performance of diverse bioassay protocols on a common chip format. With the current 64-bit processor, 1.84 Â 10 19 unique states can be defined for each step of a program. This, in combination with the capabilities described above, demonstrates an unprecedented level of programmability for the automation of microfluidic bioassays. The scaling of the current device is only limited by the one-to-one correspondence between off-chip pneumatic solenoid actuators to microvalves in the array. Up to 96 solenoid valves could easily be controlled by a single USB input/output card (National Instruments, USB-6509, Austin, TX). However, we have previously shown that binary demultiplexing pneumatic circuits connected to pneumatic latching valves enable the control of 2 NÀ1 microfluidic valves using N off-chip controllers. 15 Although the longer actuation times required for the demultiplexed latching valves (O120 ms) would reduce the speed of the digital microfluidic automaton, further design optimization of these structures may enable more rapid sample processing capabilities.
MICROFLUIDIC EMULSION GENERATOR ARRAY
Single-cell analysis is imperative to understanding cellular heterogeneity, which underlies mechanisms in complex biological systems and diseases, such as cancer. Monolithic membrane valve technology has enabled the development of a microfluidic platform for high-performance single-cell genetic analysis (SCGA). As illustrated in Figure 7A , we have devised a microfluidic emulsion generator array (MEGA) device with an integrated micropump that operates four parallel cross injectors for aqueous droplet formation. 16 The micropump consists of a serial array of three microvalves connected through a via hole to a microfabricated network enclosed between two thermally bonded glass wafers. 17 The microfluidic network is composed of symmetrically bifurcated microchannels to form four parallel crosses or droplet nozzles at the junctions. This system is used to partition individual cells within the droplets for highthroughput genetic screening applications.
On-chip pumping confers the capability of on-demand generation of droplets with well-controlled frequency and droplet size. The on-chip pump drives an aqueous PCR mix into the cross injector where it is pinched by the oil flow infused from side channels (Fig. 7B, images 1 and 2) . Because of the pulsatile nature of valve actuation, the aqueous solution is pulled back at the end of one pumping stroke, causing the release of the droplets (images 3 and 4). As a result, the frequency of droplet formation is controlled by the pump actuation frequency. In addition, the droplet size can be independently tuned by varying the actuation pressure to change the flow rate of pumped fluid. In contrast, other passive microfluidic droplet techniques, such as flow focusing, rely on the interfacial instability to form droplets, which involves complicated interplay between many parameters, including channel geometry, flow rates of two phases, and surfactant. 18e20 We found that the pulsatile pumping allows effective transport of large microbeads against gravity sedimentation to ensure the predictable stochastic encapsulation of single beads/cells into uniform nanoliter droplets (Fig. 7C) . The size deviation of 3-nL droplets was found to be 3.8%, comparable to that reported by using passive microdroplet array generators (1.3-nL droplets, coefficient of variation 3.7%). 20 These results demonstrate that our technique presents a robust platform for actively controlled generation of uniform nanoliter droplets, which is crucial to achieve quantitative single-cell genetic measurement.
Our microfluidic technique is readily scalable, as the fourchannel array defines a basic unit for multiplexed MEGA devices. To achieve a higher density, we have designed a novel ring micropump composed of three pairs of coaxial ring-shaped valve seats connected by offset channels, and corresponding circular displacement trenches. This compact micropump permits the high-density integration of 96 T-shaped droplet generation channels on a 4-in. wafer (Fig. 8) . A custom-made assembly module is used to deliver reagents and collect droplets from the 96-channel MEGA. The 96-channel MEGA system has a maximum droplet production rate of 3.4 Â 10 6 droplets per hour, which greatly improves the detection limit and processing time for detection of low-frequency events.
We have used the 96-channel MEGA to perform highthroughput bead-based multiplex PCR assays for single-cell genotyping. Multiplex SCGA enables the detection and quantification of both normal and mutant cells by targeting genes specific to individual cell types. In this approach, beads and cells are diluted in the PCR mix and partitioned into individual uniform reaction droplets dispersed in a carrier oil phase using a MEGA device. Statistical distribution of single beads and cells leads to a fraction of droplets containing both one bead and one or more cells. Beads are functionalized with forward primers targeting both cell types, and the PCR mix contains reverse primers each labeled with a unique fluorescent dye. Thousands of such droplets, generated by MEGA chips within minutes, are collected in standard PCR tubes and thermally cycled in parallel. Post-PCR beads are recovered from the emulsion and rapidly analyzed by flow cytometry for multicolor fluorescent digital counting of each single-cell detection event. Beads coexisting with only one cell type will carry one type of dye-labeled doublestranded amplicons, while beads compartmentalized with different types of target cells will be labeled with two dyes.
We have applied the MEGA devices for low-frequency detection of pathogenic Escherichia coli (E. coli) O157 bacteria in a background of nonpathogenic E. coli K12 cells ( Fig. 9 ). Quantitative detection of low-frequency O157 cells can be achieved at an average cell concentration up to 100 E. coli cells per 2.5-nL droplet, which greatly increases the analysis throughput and hence the detection sensitivity, without excessively extending the droplet production time (Fig. 9A ). This result indicates that the use of nanoliter droplets provides sufficient reagents for efficient and specific multiplex PCR amplification, and confers tolerance to PCR inhibition, as the inhibitors released from cells are significantly diluted in the large droplets. This performance would be very challenging using picoliter droplets. Compared with other droplet-format microdevices for PCR assays, such as electrowettingon-dielectric chip 21 and SlipChip, 22 our method offers the ability of automated mixing and single bead/cell encapsulation with much higher throughput.
A detection limit of 1/10 5 has been achieved by screening w10 6 cells with only 30 min of droplet generation when using the 96-channel MEGA (Fig. 9B) . The entire procedure, including PCR thermal cycling, post-PCR cleanup, and flow cytometry takes approximately 4 h and compares favorably to standard PCR-based detection assays while providing much better sensitivity. Our quantitative digital format outperforms previously reported microsystems, which detect only one bacterial strain by PCR with detection limits ranging from a few to 10 4 bacterial cells. 23e25 Because our multiplex SCGA approach digitally detects single cells, the detection limit can be further improved to 1/10 6 or lower by extending droplet generation time to analyze more cells. Such sensitivity makes the technique a promising candidate for many applications, such as food safety, where microbial pathogen detection needs to meet a zero tolerance policy for many foods. 26 These results also indicate the feasibility of the MEGA platform for other applications, for instance, the analysis of cancer development and progression, circulating tumor cells, and stem-cell differentiation, where high-throughput genetic variation analysis of mammalian cells at the single cell level may facilitate a deeper understanding of the biological mechanisms involved. During this phase, the aminophenyl fluorescein is oxidized to form a highly fluorescent product. After rinsing the enzymatic detection circuit, the stored H 2 O 2 dilution is further diluted and the program is repeated to generate a standard curve. Finally, 120-nL samples are loaded and mixed with detection reagents for quantification. (B) Confocal fluorescence data acquired from the detection circuit during the performance of the assay. Arrows indicate the points in the assay where mixing is complete and data are collected.
SUMMARY
Advances in monolithic membrane valve technology have enabled the development of robust platforms for digital microfluidic assay automation. The programmability, speed, throughput, and low-sample volume requirements conferred by these systems offer significant advantages compared with conventional benchtop robotic laboratory automation systems and specialized microfluidic processing platforms. The digital transfer of fluids between microvalves in the microfluidic automaton platform enables the implementation of diverse serial and combinatorial sample processing operations on a common chip format. The programmability of this platform can be exploited to replace the specialized microfluidic circuits used in conventional lab-on-a chip devices. Similarly, the use of microvalve pumps in the MEGA platform enables high-throughput droplet generation with programmable droplet volumes and formation rates. This programmability has been instrumental for high-throughput screening of single cells for low-frequency genetic variations. These Hz. PCR mix is pumped through the cross injector and pinched by the oil flow infused from side channels (images 1 and 2). The aqueous solution is pulled back at the end of each pumping cycle, which causes the release of the droplets (images 3 and 4). As a result, the droplet formation is synchronized with the pump actuation, and the droplet size is determined by the flow rate of pumped fluid. (C) Optical micrograph of highly uniform droplets generated by our method containing a predictable stochastic distribution of primer-functionalized agarose beads (w34 mm, indicated by arrows). For this experiment, the average bead concentration was 0.1 beads per 3-nL droplet. 
